UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000045535 |
|---|---|
| Receipt number | R000051991 |
| Scientific Title | Multicenter study of acinar cell carcinoma in Japan |
| Date of disclosure of the study information | 2021/09/21 |
| Last modified on | 2021/09/21 22:59:03 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Multicenter study of acinar cell carcinoma in Japan
Acronym
Multicenter study of acinar cell carcinoma
Scientific Title
Multicenter study of acinar cell carcinoma in Japan
Scientific Title:Acronym
Multicenter study of acinar cell carcinoma
Region
| Japan |
Condition
Condition
acinar cell carcinoma
Classification by specialty
| Hepato-biliary-pancreatic medicine | Hepato-biliary-pancreatic surgery |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
The aim of this study is to examine the clinic-pathologic features of patients with acinar cell carcinoma
Basic objectives2
Others
Basic objectives -Others
To reveal the pathological grading of acinar cell carcinoma
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
To reveal the clinic-pathologic features of patients with acinar cell carcinoma
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 1 | years-old | <= |
Age-upper limit
| 100 | years-old | > |
Gender
Male and Female
Key inclusion criteria
The patients with acinar cell carcinoma diagnosed histologically by resection or EUS-FNA between January 2000 and December 2020
Key exclusion criteria
The cases without component of acinar cell carcinoma
The cases without histlogical diagnosis
Target sample size
200
Research contact person
Name of lead principal investigator
| 1st name | Atsushi |
| Middle name | |
| Last name | Kanno |
Organization
Jichi Medical University
Division name
Department of Medicine, Division of Gastroenterology
Zip code
329-0498
Address
3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan
TEL
0285-58-7348
atsushih@jichi.ac.jp
Public contact
Name of contact person
| 1st name | Atsushi |
| Middle name | |
| Last name | Kanno |
Organization
Jichi Medical University
Division name
Department of Medicine, Division of Gastroenterology
Zip code
329-0498
Address
3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan
TEL
0285-58-7348
Homepage URL
atsushih@jichi.ac.jp
Sponsor or person
Institute
Japan Pancreas Society
Institute
Department
Personal name
Funding Source
Organization
Japan Pancreas Society
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Support Center for Clinical Investigation, Jichi Medical University
Address
3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan
Tel
0285-58-8933
rinri@jichi.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2021 | Year | 09 | Month | 21 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2021 | Year | 04 | Month | 08 | Day |
Date of IRB
| 2021 | Year | 05 | Month | 07 | Day |
Anticipated trial start date
| 2021 | Year | 10 | Month | 01 | Day |
Last follow-up date
| 2026 | Year | 09 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
This was a retrospective, observational study that examined the clinic-pathologic features of patients with acinar cell carcinoma diagnosed between January 2000 and December 2020.
Management information
Registered date
| 2021 | Year | 09 | Month | 21 | Day |
Last modified on
| 2021 | Year | 09 | Month | 21 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051991
